3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Cutaneous Squamous Cell Carcinoma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Advanced Non-Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Interventions
Rituximab
40
Cyclophosphamide
29
Etoposide
15
Doxorubicin
14
Vincristine
13
Prednisone
13
ibrutinib
10
fludarabine
10
fludarabine phosphate
8
Cytarabine
8
Mycophenolic Acid
7
Bortezomib
7
Lenalidomide
6
Carmustine
6
pembrolizumab
5
Peripheral Blood Stem Cell Transplantation
5
Melphalan
5
Inotuzumab Ozogamicin
5
Whole-Body Irradiation
4
Tacrolimus
4
Carboplatin
4
CT-P10
4
Brentuximab Vedotin
4
Antilymphocyte Serum
4
tositumomab I-131
3
tocilizumab
3
tazemetostat
3
obinutuzumab
3
idelalisib
3
etoposide phosphate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, B-Cell
×
cemiplimab
×
Clear all
No trials found.